Aveanna Healthcare Enters New Agreements, Terminates Others

TL;DR

Aveanna Healthcare is juggling new deals and ditching old ones, creating new financial obligations.

AI Summary

On September 17, 2025, Aveanna Healthcare Holdings Inc. entered into a material definitive agreement and terminated another. The company also created a direct financial obligation or an obligation under an off-balance sheet arrangement. Specific details regarding the nature of these agreements, terminations, and financial obligations were not provided in this filing.

Why It Matters

This filing indicates significant changes in Aveanna Healthcare's contractual and financial arrangements, which could impact its operational structure and financial obligations.

Risk Assessment

Risk Level: medium — The filing indicates significant changes in material agreements and financial obligations, the details of which are not fully disclosed, creating uncertainty.

Key Players & Entities

• Aveanna Healthcare Holdings Inc. (company) — Registrant
• 001-40362 (company) — SEC File Number
• 81-4717209 (company) — IRS Employer Identification No.
• September 17, 2025 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share AVAH The Nasdaq Stock Mar
• $885,950,000 — nding balance as of the Closing Date of $885,950,000 (the "Existing Term Loans") and a $170,
• $170,330,000 — 0,000 (the "Existing Term Loans") and a $170,330,000 senior secured revolving credit facilit
• $79,670,000 — nts in an aggregate principal amount of $79,670,000, resulting in total aggregate revolving
• $250,000,000 — aggregate revolving loan commitments of $250,000,000 (the "2025 Refinancing Revolving Credit
• $439,050,000 — with aggregate commitments increased by $439,050,000 (the "2025 Incremental Term Loans"). Co
• $1,325,000,000 — gregate to a total principal balance of $1,325,000,000 (the "2025 Term Loans"). The 2025 Refin
• $415.0 million — oan in an aggregate principal amount of $415.0 million (the "Second Lien Term Loan"), which wa

Filing Documents

• avah-20250917.htm (8-K) — 57KB
• avah-ex10_1.htm (EX-10.1) — 3270KB
• avah-ex99_1.htm (EX-99.1) — 9KB
• img25599489_0.jpg (GRAPHIC) — 42KB
• img45841609_0.jpg (GRAPHIC) — 34KB
• 0001193125-25-206824.txt ( ) — 3987KB
• avah-20250917.xsd (EX-101.SCH) — 23KB
• avah-20250917_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On September 17, 2025 (the "Closing Date"), Aveanna Healthcare LLC, a Delaware limited liability company (the "Borrower"), a wholly owned subsidiary of Aveanna Healthcare Holdings, Inc. (the "Company"), entered into the fourth joinder and twelfth amendment (the "Refinancing Amendment") to its First Lien Credit Agreement, dated as of March 16, 2017 (as further amended, supplemented, or otherwise modified from time to time as of the date hereof, the "Existing Credit Agreement"), among the Company, the borrowing subsidiaries party thereto, the lenders party thereto, Barclays Bank PLC as administrative agent and collateral agent (in such capacities, the "Administrative Agent"), and other agents party thereto (the Existing Credit Agreement, as amended by the Refinancing Amendment, the "Amended Credit Agreement"). The Existing Credit Agreement provided for among other things, a senior secured term loan facility (the "Existing Term Loan Facility") with an outstanding balance as of the Closing Date of $885,950,000 (the "Existing Term Loans") and a $170,330,000 senior secured revolving credit facility (the "Existing Revolving Credit Facility"). The Refinancing Amendment provides for, among other things, the refinancing of the Existing Revolving Credit Facility under the Existing Credit Agreement and incremental revolving loan commitments in an aggregate principal amount of $79,670,000, resulting in total aggregate revolving loan commitments of $250,000,000 (the "2025 Refinancing Revolving Credit Facility"), a portion of which may be used for the issuance of letters of credit and swingline loans. The Refinancing Amendment additionally provides for the refinancing of the Existing Term Loans ("2025 Refinancing Term Loans") under the Existing Term Loan Facility (the "2025 Refinancing Term Facility") and an incremental senior secured term loan facility (the "2025 Incremental Term Facility"), with aggregate commitments incr

02 Termination of a Material Definitive Agreement

Item 1.02 Termination of a Material Definitive Agreement. The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 1.02. On September 17, 2025, substantially concurrently with the Refinancing Amendment described in Item 1.01, the Borrower terminated its Second Lien Credit Agreement, dated as of December, 10, 2021, by and among the Company, the Borrower, a syndicate of lending institutions from time to time party thereto, and Barclays Bank PLC, as administrative agent and collateral agent (the "Second Lien Credit Agreement"). The Second Lien Credit Agreement provided for a second lien term loan in an aggregate principal amount of $415.0 million (the "Second Lien Term Loan"), which was secured by a second lien on certain collateral specified therein. The entirety of the Second Lien Term Loan was repaid with proceeds from the 2025 Incremental Term Loans referenced into Item 1.01. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

01 Other Events

Item 8.01 Other Events. On September 18, 2025, the Company issued a press release announcing the Refinancing Amendment and the Amended Credit Agreement, and the termination of the Second Lien Credit Agreement. The full text of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1* Fourth Joinder and Twelfth Amendment to First Lien Credit Agreement dated as of September 17, 2025, among Aveanna Healthcare LLC, Aveanna Healthcare Intermediate Holdings LLC, the other credit parties thereto, the lenders party thereto, the L/C issuers party thereto, and Barclays Bank PLC, as administrative agent and swingline lender. 99.1 Press Release dated September 18, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Pursuant to item 601(a)(5) of Regulation S-K, certain exhibits and schedules to this agreement have been omitted. The registrant agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted exhibits or schedule upon request by the Securities and Exchange Commission.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVEANNA HEALTHCARE HOLDINGS INC. Date: September 18, 2025 By: /s/ Matthew Buckhalter Matthew Buckhalter Chief Financial Officer (Principal Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR